My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study.

    Mastrandrea L, Yu J, Behrens T, Buchlis J, Albini C, Fourtner S, Quattrin T.

    Diabetes Care. 2009 Jul;32(7):1244-9. Epub 2009 Apr 14.PMID: 19366957 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.

    Sankar V, Brennan MT, Kok MR, Leakan RA, Smith JA, Manny J, Baum BJ, Pillemer SR.

    Arthritis Rheum. 2004 Jul;50(7):2240-5.PMID: 15248223 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial.

    Raz I, Avron A, Tamir M, Metzger M, Symer L, Eldor R, Cohen IR, Elias D.

    Diabetes Metab Res Rev. 2007 May;23(4):292-8.PMID: 17124720 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials.

    Schloot NC, Meierhoff G, Lengyel C, Vándorfi G, Takács J, Pánczél P, Barkai L, Madácsy L, Oroszlán T, Kovács P, Sütö G, Battelino T, Hosszufalusi N, Jermendy G.

    Diabetes Metab Res Rev. 2007 May;23(4):276-85.PMID: 17103487 [PubMed - indexed for MEDLINE]Related articles

    5.

    Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.

    Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL.

    Clin Ther. 2007 Jan;29(1):74-83.PMID: 17379048 [PubMed - indexed for MEDLINE]Related articles

    6.

    Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.

    Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA.

    Clin Ther. 2005 Aug;27(8):1181-95.PMID: 16199244 [PubMed - indexed for MEDLINE]Related articles

    7.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    8.

    Etanercept and efalizumab for the treatment of psoriasis: a systematic review.

    Woolacott N, Hawkins N, Mason A, Kainth A, Khadjesari Z, Vergel YB, Misso K, Light K, Chalmers R, Sculpher M, Riemsma R.

    Health Technol Assess. 2006 Nov;10(46):1-233, i-iv. Review.PMID: 17083854 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

    Roberts VL, Stewart J, Issa M, Lake B, Melis R.

    Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

    10.

    A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.

    Papp KA, Tyring S, Lahfa M, Prinz J, Griffiths CE, Nakanishi AM, Zitnik R, van de Kerkhof PC, Melvin L; Etanercept Psoriasis Study Group.

    Br J Dermatol. 2005 Jun;152(6):1304-12.PMID: 15948997 [PubMed - indexed for MEDLINE]Related articles

    11.

    Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

    Rosenstock J, Brazg R, Andryuk PJ, Lu K, Stein P; Sitagliptin Study 019 Group.

    Clin Ther. 2006 Oct;28(10):1556-68.PMID: 17157112 [PubMed - indexed for MEDLINE]Related articles

    12.

    Etanercept treatment for children and adolescents with plaque psoriasis.

    Paller AS, Siegfried EC, Langley RG, Gottlieb AB, Pariser D, Landells I, Hebert AA, Eichenfield LF, Patel V, Creamer K, Jahreis A; Etanercept Pediatric Psoriasis Study Group.

    N Engl J Med. 2008 Jan 17;358(3):241-51.PMID: 18199863 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials.

    Buse JB, Klonoff DC, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Maggs DG, Wintle ME.

    Clin Ther. 2007 Jan;29(1):139-53.PMID: 17379054 [PubMed - indexed for MEDLINE]Related articles

    14.

    Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

    Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin JM, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L.

    N Engl J Med. 2005 Jun 23;352(25):2598-608.PMID: 15972866 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.

    Martínez-Taboada VM, Rodríguez-Valverde V, Carreño L, López-Longo J, Figueroa M, Belzunegui J, Mola EM, Bonilla G.

    Ann Rheum Dis. 2008 May;67(5):625-30. Epub 2007 Dec 17.PMID: 18086726 [PubMed - indexed for MEDLINE]Related articles

    16.

    Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial.

    Madsbad S, Schmitz O, Ranstam J, Jakobsen G, Matthews DR; NN2211-1310 International Study Group.

    Diabetes Care. 2004 Jun;27(6):1335-42.PMID: 15161785 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.

    Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Grassnickel L, Rudwaleit M, Sieper J, Braun J.

    Arthritis Rheum. 2003 Jun;48(6):1667-75.PMID: 12794835 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.

    Weisman MH, Paulus HE, Burch FX, Kivitz AJ, Fierer J, Dunn M, Kerr DR, Tsuji W, Baumgartner SW.

    Rheumatology (Oxford). 2007 Jul;46(7):1122-5. Epub 2007 Apr 29.PMID: 17470434 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes.

    Covington P, Christopher R, Davenport M, Fleck P, Mekki QA, Wann ER, Karim A.

    Clin Ther. 2008 Mar;30(3):499-512.PMID: 18405788 [PubMed - indexed for MEDLINE]Related articles

    20.

    Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial.

    Coutant R, Landais P, Rosilio M, Johnsen C, Lahlou N, Chatelain P, Carel JC, Ludvigsson J, Boitard C, Bougnères PF.

    Diabetologia. 1998 Sep;41(9):1040-6.PMID: 9754822 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity